论文部分内容阅读
目的分析1例接种ACYW_(135)群脑膜炎球菌多糖疫苗(group ACYW_(135)meningococcal polysaccharide vaccine,MPV-ACYW_(135))后偶合发生Miller-Fisher综合征案例,为类似案例处置提供参考。方法收集患儿的疾病资料、接种资料,疫苗批签发、运转、管理资料,结合现场检查进行调查。结果患儿所患疾病Miller-Fisher综合征与接种MPVACYW_(135)因果关系依据不充分,为偶合症。结论调查诊断时不仅要充分收集接种前后的患病就诊资料,也需在合适的时间内补充开展辅助检查。预防接种人员在实施接种的过程中,需仔细了解受种者的健康状况,掌握疫苗禁忌症,减少偶合疾病的发生。
Objective To analyze the case of Miller-Fisher syndrome caused by inoculation of ACYW_ (135) meningococcal polysaccharide vaccine (MPV-ACYW_ (135)) and to provide reference for the treatment of similar cases. Methods Children’s disease data, vaccination data, vaccine batch issuance, operation and management information were collected and investigated in combination with on-site inspection. Results The Miller-Fisher syndrome in children with MPVACYW_ (135) and the causality were not adequately based on the causation. Conclusions The investigation and diagnosis should not only fully collect the pre-vaccination information but also supplement the auxiliary examinations within the appropriate time. Vaccinations in the implementation of vaccination process, the need to carefully understand the health of the recipient, to master the vaccine contraindications and reduce the incidence of coupling disease.